120 related articles for article (PubMed ID: 18803276)
1. Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.
Gonlugur TE; Gonlugur U
J Clin Lab Anal; 2008; 22(5):334-6. PubMed ID: 18803276
[TBL] [Abstract][Full Text] [Related]
2. Pleural fluid analysis in malignant mesothelioma. Prognostic implications.
Gottehrer A; Taryle DA; Reed CE; Sahn SA
Chest; 1991 Oct; 100(4):1003-6. PubMed ID: 1914546
[TBL] [Abstract][Full Text] [Related]
3. A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma.
Tanrikulu AC; Abakay A; Kaplan MA; Küçüköner M; Palanci Y; Evliyaoglu O; Sezgi C; Sen H; Carkanat Aİ; Kirbas G
Respiration; 2010; 80(6):480-7. PubMed ID: 20881372
[TBL] [Abstract][Full Text] [Related]
4. Malignant pleural effusions in lymphoproliferative disorders.
Ahmed S; Shahid RK; Rimawi R; Siddiqui AK; Rossoff L; Sison CP; Steinberg H; Rai KR
Leuk Lymphoma; 2005 Jul; 46(7):1039-44. PubMed ID: 16019555
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality within three months in the patients with malignant pleural effusion.
Ozyurtkan MO; Balci AE; Cakmak M
Eur J Intern Med; 2010 Feb; 21(1):30-4. PubMed ID: 20122610
[TBL] [Abstract][Full Text] [Related]
6. Elevated aspartate aminotransferase and monocyte counts predict unfavorable prognosis in patients with malignant pleural mesothelioma.
Zhang A; Cao S; Jin S; Cao J; Shen J; Pan B; Zhu R; Yu Y
Neoplasma; 2017; 64(1):114-122. PubMed ID: 27881012
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of pleural fluid data in patients with malignant effusion.
Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Thomas R; Cheah HM; Creaney J; Turlach BA; Lee YC
Chest; 2016 Jun; 149(6):1494-500. PubMed ID: 26836920
[TBL] [Abstract][Full Text] [Related]
10. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
11. Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival.
Strizzi L; Muraro R; Vianale G; Natoli C; Talone L; Catalano A; Mutti L; Tassi G; Procopio A
J Pathol; 2002 Jun; 197(2):218-23. PubMed ID: 12015746
[TBL] [Abstract][Full Text] [Related]
12. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
13. Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
Hegmans JP; Veltman JD; Fung ET; Verch T; Glover C; Zhang F; Allard WJ; T'Jampens D; Hoogsteden HC; Lambrecht BN; Aerts J
Technol Cancer Res Treat; 2009 Oct; 8(5):323-32. PubMed ID: 19754208
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
[TBL] [Abstract][Full Text] [Related]
15. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
Scherpereel A; Grigoriu B; Conti M; Gey T; Grégoire M; Copin MC; Devos P; Chahine B; Porte H; Lassalle P
Am J Respir Crit Care Med; 2006 May; 173(10):1155-60. PubMed ID: 16456138
[TBL] [Abstract][Full Text] [Related]
16. [Pleural mesothelioma: experience with 62 cases in 9 years].
Villena Garrido V; López Encuentra A; Echave-Sustaeta J; Alvarez Martínez C; Rey Terrón L; Sotelo MT; Ballestín C
Arch Bronconeumol; 2004 May; 40(5):203-8. PubMed ID: 15117619
[TBL] [Abstract][Full Text] [Related]
17. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
Charvat JC; Brutsche M; Frey JG; Tschopp JM
Praxis (Bern 1994); 1998 Mar; 87(10):336-40. PubMed ID: 9545840
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma.
Thylén A; Hjerpe A; Martensson G
Cancer; 2001 Sep; 92(5):1224-30. PubMed ID: 11571736
[TBL] [Abstract][Full Text] [Related]
20. Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters.
Alexandrakis MG; Kyriakou D; Alexandraki R; Pappa KA; Antonakis N; Bouros D
Respiration; 2002; 69(3):201-6. PubMed ID: 12097761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]